Viewing nowIzaltan Tablet 150 mg (Irbesartan)
Irbesartan 150mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201101755 · Approved 2011.03.29 · Insurance code 643505920
Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension
This medication is used in the treatment of hypertension, including essential hypertension. Additionally, it helps to prevent or suppress the progression of nephropathy in patients with type 2 diabetes who have hypertension. This drug effectively controls blood pressure, reducing the risk of complications and improving patient health.
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan 150 mg orally once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in certain cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive may be administered concomitantly. The effect is increased particularly when administered concomitantly with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this medicine once daily and increase the dose to 300 mg for maintenance. Another antihypertensive may be administered concomitantly, if necessary, to achieve the target blood pressure. ○ Elderly patients Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients aged 75 years and older. ○ Patients with renal impairment Dosage adjustment is generally not necessary; however, an initial dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment No specific dosage adjustment is generally necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.
This medication can cause serious harm to the fetus and neonate, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients who are allergic to this drug or its components, pregnant or nursing women, patients with severe liver impairment, patients with hereditary angioedema, patients with diabetes or severe renal impairment should not take this medication. Caution is warranted for elderly patients, patients with hyperkalemia, those with liver disease, heart disease patients, patients with decreased blood volume, and those with renal dysfunction, and careful monitoring and testing by a physician may be necessary as needed. Generally, the side effects of this drug are mild and temporary; however, symptoms such as dizziness, headaches, muscle pain, fatigue, dyspepsia, and rashes may occur. Severe side effects such as angioedema, hyperkalemia, hypotension, renal failure, liver dysfunction, hypoglycemia, and muscle disorders may occur, and medical personnel should be notified immediately if symptoms arise. This medication can affect liver and kidney function, so patients with liver or renal abnormalities should undergo regular blood tests and physical condition assessments. Due to its strong blood pressure-lowering effect, care should be taken when taking this with other antihypertensive medications to avoid hypotension or electrolyte imbalance. When taken with potassium supplements or potassium-sparing diuretics, the blood potassium level may rise to dangerous levels, so co-administration should be avoided or done under medical supervision. Interactions may also occur when taken with lithium or nonsteroidal anti-inflammatory drugs (NSAIDs), so consultation with medical personnel is needed. Women who are pregnant or planning to become pregnant should not take this drug, and nursing women are advised to discontinue breastfeeding if they take this medication. Safety in children has not been established, so it is preferable not to use it in pediatric patients. Elderly patients should begin with a low dose and use it cautiously due to the risk of excessive blood pressure reduction leading to stroke or similar risks. In case of overdose, symptoms such as hypotension, tachycardia, and bradycardia may appear and immediate treatment is required, as this medication cannot be removed by dialysis. This medication should be kept out of the reach of children and should be stored in its original container as transferring to another container may degrade its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering and should be kept in a cool, dry place below 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIrbesartan 150mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Handok Co., Ltd.

Irbesartan 300mg
Tablet · Prescription medication
Handok Co., Ltd.
Irbesartan 150mg
Tablet · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.
Irbesartan 150mg
Prescription medication
Bionex Co., Ltd.

Irbesartan 150mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.